05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
With the uncertainty of COVID-19 impacting construction projects in new and unfamiliar ways, choosin...
Read More >
Q: We recently terminated an employee and are paying severance for several weeks; however, the emplo...
Read More >
The Ninth Circuit, in back-to-back opinion and memorandum decisions in Dorman v. Charles Schwab Corp...
Read More >
The U.S. Court of Appeals for the Second Circuit recently ruled that a New York-based affiliate of a...
Read More >
BakerHostetler presents its inaugural Texas M&A Trends alert. Each quarter, we will present data reg...
Read More >
The long-promised new Form I-9 is now available for use and downloading from the USCIS website. Alth...
Read More >